Skip to main content
. Author manuscript; available in PMC: 2015 Nov 25.
Published in final edited form as: Urology. 2015 May;85(5):1111–1116. doi: 10.1016/j.urology.2015.02.014

Table 1.

Baseline characteristics by serum PSA concentration at baseline, Korean Heart Study, 1994-2011*

Serum PSA Concentration, ng/mL P Trend
<1.0 1.0-1.9 2.0-3.9 4.0-9.9 ≥10.0
N 71,524 36,809 8313 1747 272
Mean (SE) age, y 45.6 (0.0) 48.1 (0.1) 52.6 (0.1) 56.4 (0.2) 60.3 (0.6) <.0001
Mean (SE) body mass index, kg/m2 23.9 (0.0) 23.8 (0.0) 23.7 (0.0) 23.8 (0.1) 23.6 (0.2) <.0001
Mean (SE) systolic blood pressure, mm Hg 124.0 (0.1) 123.8 (0.1) 124.6 (0.2) 125.1 (0.4) 123.8 (1.0) .033
Mean (SE) diastolic blood pressure, mm Hg 77.9 (0.0) 78.1 (0.1) 78.2 (0.1) 77.3 (0.3) 75.0 (0.7) .65
Mean (SE) total cholesterol, mg/dL 195.1 (0.1) 195.6 (0.2) 195.1 (0.4) 194.2 (0.8) 193.1 (2.1) .65
Mean (SE) fasting glucose, mg/dL 101.2 (0.1) 99.1 (0.1) 98.6 (0.3) 97.1 (0.6) 96.0 (1.5) <.0001
Mean (SE) PSA, ng/mL 0.6 (0.0) 1.3 (0.0) 2.5 (0.0) 5.5 (0.0) 19.3 (0.0) <.0001
Smoking status (%)
 Never 22.2 21.8 23.3 25.3 26.5 <.0001
 Past 23.8 27.2 30.9 33.0 34.9
 Current 54.1 51.0 45.8 41.7 38.6

PSA, prostate-specific antigen; SE, standard error of the mean.

*

Adjusted for age.